# Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-hd-26-001-development-of-novel-or-improved-infertility-technologies/  
Official notice: https://www.grants.gov/search-results-detail/359144

> National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 20, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-HD-26-001 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | November 20, 2025 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.865 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.

## What the grant funds

The purpose of this notice of funding opportunity (NOFO) is to support and facilitate multidisciplinary research approaches for the development or improvement of technologies, including drugs, devices, products, or clinical practices designed to improve fertility outcomes in patients dealing with infertility, particularly in the context of Assisted Reproductive Technologies (ART). This NOFO aims to position innovative and validated technologies for future clinical development.

## Questions people ask

### Is RFA-HD-26-001 still open?

No. It closed on November 20, 2025.

### Who can apply for Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)?

Closed November 20, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-HD-26-001?

NIH RePORTER lists 12 projects funded under RFA-HD-26-001 in fiscal 2026, at 11 institutions. The most were at Washington University, Yale University, Atera Medical.

### Who has won Child Health and Human Development Extramural Research grants before?

The largest recipients over five fiscal years were Regents of the University of Michigan, The Johns Hopkins University, University of Washington. The program made 6,026 awards worth $6.0 billion in that time.